Verastem Inc 's Revenue in the fiscal year 2025 $ 30.91 millions
Verastem Inc 's Revenue in the fiscal year 2024 $ 10.00 millions
Verastem Inc 's Revenue in the fiscal year 2023 $ 0.00 millions
Verastem Inc 's Revenue in the fiscal year 2022 $ 2.60 millions
Verastem Inc 's Revenue in the fiscal year 2021 $ 2.05 millions
VSTM Revenue second quarter 2026 Y/Y Growth Comment
Verastem Inc achieved in the second quarter 2026, above Company average Revenue surge of 1772.8% year on year, to $ 40.08 millions.
Looking into second quarter 2026 results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Revenue growth. While Verastem Inc ' s Revenue doubling of 1772.8% ranks overall at the positon no. 36 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Verastem Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
27150 %
1416.51 %
-100 %
(Dec 31 2021)
VSTM's II. Quarter Q/Q Revenue Comment
Verastem Inc achieved in the II. Quarter 2026 below company average Revenue doubling of 114.67% quarter on quarter, to $ 40.08 millions.
Although the II. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the II. Quarter surge, eclipses the % growth in the II. Quarter a year ago
Within Major Pharmaceutical Preparations industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Verastem Inc 's Revenue growth quarter on quarter, overall rank is 123.
Verastem Inc achieved in the II. Quarter 2026 below company average Revenue doubling of 114.67% quarter on quarter, to $ 40.08 millions.
II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the % in the II. Quarter a year ago.
Within Major Pharmaceutical Preparations industry 24 other companies have achieved higher Revenue quarter on quarter growth. While Verastem Inc 's Revenue growth quarter on quarter, overall rank is 123.
Verastem Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 87.53
$ 49.59
$ 0.00
$ 0.00
$ 0.00
Y / Y Revenue Growth (TTM)
-
-
-
-
-
Year on Year Revenue Growth Overall
Ranking
#
#
#
#
#
Seqeuential Revenue Change (TTM)
76.52 %
-
-
-
-
Seq. Revenue Growth (TTM) Overall
Ranking
#
#
#
#
#
Cumulative Revenue growth Comment
Verastem Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 1772.8% year on year, to $ 88 millions if the fiscal year would have ended in Jun 30 2026. Verastem Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Verastem Inc realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry. But from twelve months ended Mar 31 2026 rise was beneth at 76.52 % from $49.59 millions achieved in the period from Mar 31 2026 to Jun 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at130.24%.
Verastem Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
Verastem Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 1772.8% year on year, to $ 88 millions if the fiscal year would have ended in Jun 30 2026. Verastem Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Verastem Inc realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry. But from twelve months ended Mar 31 2026 rise was beneth at 76.52 % from $49.59 millions achieved in the period from Mar 31 2026 to Jun 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at130.24%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 76.52 % increase from $49.59 millions in the period from Mar 31 2026 to Jun 30 2025.
Verastem Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
About Verastem Inc Revenue Growth Rates (VSTM), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
2,778.55%